Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Donald I. Abrams Joins NEMUS' SAB

This article was originally published in Scrip

Executive Summary

NEMUS Bioscience, Inc. has appointed Donald I. Abrams to its scientific advisory board (SAB). Abrams is currently professor of clinical medicine at the University of California and chief of the hematology-oncology division at San Francisco General Hospital. He is also an integrative oncologist at the U.C.S.F. Osher Center for Integrative Medicine and was co-editor of the Oxford University Press textbook of Integrative Oncology. Previously, Abrams was president of the Society of Integrative Oncology and is a member of the National Cancer Institute's (NCI) Physician Data Query: Complementary and Alternative Medicine editorial board.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel